Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Reasons To Buy
What was the size of the China biotechnology market by value in 2016?
What will be the size of the China biotechnology market in 2021?
What factors are affecting the strength of competition in the China biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up China's biotechnology market?
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
The Chinese biotechnology market is expected to generate total revenues of $18.5bn in 2016, representing a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016.
The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $18.1bn, equivalent to 97.8% of the market's overall value.
The Chinese government is seeking to help the domestic biotechnology industry through the creation of biotech zones and preferential regulations to locally produced drugs. It is hoped this will move Chinese companies away from cheap, generic drugs.
Market value forecast
Market value forecast
Five Forces Analysis
Threat of substitutes
Degree of rivalry
Novo Nordisk A/S
Shanghai Kehua Bio-engineering Co., Ltd
Sinovac Biotech Ltd.
Related MarketLine research
Figure 1: China biotechnology industry value: $ million, 2012-16(e)
Figure 2: China biotechnology industry category segmentation: % share, by value, 2016(e)
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2016(e)
Figure 4: China biotechnology industry value forecast: $ million, 2016-21
Figure 5: Forces driving competition in the biotechnology industry in China, 2016
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2016
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2016
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2016
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2016
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2016
Figure 11: Novo Nordisk A/S: revenues & profitability
Figure 12: Novo Nordisk A/S: assets & liabilities
Figure 13: Shanghai Kehua Bio-engineering Co., Ltd: revenues & profitability
Figure 14: Shanghai Kehua Bio-engineering Co., Ltd: assets & liabilities
Figure 15: Sinovac Biotech Ltd.: revenues & profitability
Figure 16: Sinovac Biotech Ltd.: assets & liabilities
Table 1: China biotechnology industry value: $ million, 2012-16(e)
Table 2: China biotechnology industry category segmentation: $ million, 2016(e)
Table 3: China biotechnology industry geography segmentation: $ billion, 2016(e)
Table 4: China biotechnology industry value forecast: $ million, 2016-21
Table 5: Novo Nordisk A/S: key facts
Table 6: Novo Nordisk A/S: key financials ($)
Table 7: Novo Nordisk A/S: key financials (DKK)
Table 8: Novo Nordisk A/S: key financial ratios
Table 9: Shanghai Kehua Bio-engineering Co., Ltd: key facts
Table 10: Shanghai Kehua Bio-engineering Co., Ltd: key financials ($)
Table 11: Shanghai Kehua Bio-engineering Co., Ltd: key financials (CNY)
Table 12: Shanghai Kehua Bio-engineering Co., Ltd: key financial ratios
Table 13: Sinovac Biotech Ltd.: key facts
Table 14: Sinovac Biotech Ltd.: key financials ($)
Table 15: Sinovac Biotech Ltd.: key financial ratios
Table 16: China size of population (million), 2012-16
Table 17: China gdp (constant 2005 prices, $ billion), 2012-16
Table 18: China gdp (current prices, $ billion), 2012-16
Table 19: China inflation, 2012-16
Table 20: China consumer price index (absolute), 2012-16
Table 21: China exchange rate, 2012-16
Single User License:
Corporate User License:
Novo Nordisk A/S Shanghai Kehua Bio-engineering Co., Ltd Sinovac Biotech Ltd.
Biotechnology, MarketLine, China
select a license
NEWSLETTER BY CATEGORY
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"